APA

Lesuisse D., Malanda A., Peyronel J., Evanno Y., Lardenois P., De-Peretti D., Abécassis P., Barnéoud P., Brunel P., Burgevin M., Cegarra C., Auger F., Dommergue A., Lafon C., Even L., Tsi J., Luc T. P. H., Almario A., Olivier A., Castel M., Taupin V., Rooney T. & Vigé X. (20200305). Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease. : Bioorganic & medicinal chemistry letters.

Chicago

Lesuisse Dominique, Malanda André, Peyronel Jean-François, Evanno Yannick, Lardenois Patrick, De-Peretti Danielle, Abécassis Pierre-Yves, Barnéoud Pascal, Brunel Pascale, Burgevin Marie-Claude, Cegarra Céline, Auger Florian, Dommergue Amélie, Lafon Corinne, Even Luc, Tsi Joanna, Luc Thy Phuong Hieu, Almario Antonio, Olivier Anne, Castel Marie-Noëlle, Taupin Véronique, Rooney Thomas and Vigé Xavier. 20200305. Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease. : Bioorganic & medicinal chemistry letters.

Harvard

Lesuisse D., Malanda A., Peyronel J., Evanno Y., Lardenois P., De-Peretti D., Abécassis P., Barnéoud P., Brunel P., Burgevin M., Cegarra C., Auger F., Dommergue A., Lafon C., Even L., Tsi J., Luc T. P. H., Almario A., Olivier A., Castel M., Taupin V., Rooney T. and Vigé X. (20200305). Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease. : Bioorganic & medicinal chemistry letters.

MLA

Lesuisse Dominique, Malanda André, Peyronel Jean-François, Evanno Yannick, Lardenois Patrick, De-Peretti Danielle, Abécassis Pierre-Yves, Barnéoud Pascal, Brunel Pascale, Burgevin Marie-Claude, Cegarra Céline, Auger Florian, Dommergue Amélie, Lafon Corinne, Even Luc, Tsi Joanna, Luc Thy Phuong Hieu, Almario Antonio, Olivier Anne, Castel Marie-Noëlle, Taupin Véronique, Rooney Thomas and Vigé Xavier. Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease. : Bioorganic & medicinal chemistry letters. 20200305.